Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Chest|July 8, 2009
Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health studyGary T Ferguson, Peter M A Calverley, Julie A Anderson, et al.
Respiratory Research|July 2, 2009
Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyChristine R Jenkins, Paul W Jones, Peter M A Calverley, et al.
The European Respiratory Journal|September 29, 2012
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocolJørgen Vestbo, Julie Anderson, Robert D Brook, et al.
American Journal of Respiratory and Critical Care Medicine|April 1, 2022
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical TrialsPeter M A Calverley, Fernando J Martinez, Jørgen Vestbo, et al.
Thorax|August 6, 2010
Cardiovascular events in patients with COPD: TORCH study resultsPeter M A Calverley, Julie A Anderson, Bartolome Celli, et al.
ERJ Open Research|November 25, 2021
Impact of the UK lockdown on people at risk of COPDGavin C Donaldson, Andrew I Ritchie, Peter M A Calverley, et al.
Respiratory Medicine|May 18, 2010
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohortMartijn A Spruit, Michael L Watkins, Lisa D Edwards, et al.
Chest|February 16, 2013
Cardiovascular safety in patients receiving roflumilast for the treatment of COPDWilliam B White, Glen E Cooke, Peter R Kowey, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2010
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experienceBartolome Celli, Jörgen Vestbo, Christine R Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|May 31, 2008
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyBartolomé R Celli, Nicola E Thomas, Julie A Anderson, et al.
Pageof 15